Clinical Trial Update: Amylin and Glucagon-Like Peptide-1 (GLP-1): Influence on Gastric Emptying, Appetite and Food Intake in Humans

View source ↗

Summary

A completed clinical trial investigating how amylin and GLP-1 influence gastric emptying, appetite, and food intake in humans with diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)
• pramlintide (pramlintide)

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Diabetes | Status: COMPLETED